Oncology - ModernMedicine

Oncology

Editor's Choice
Competing mortality should be considered
in patients with head and neck cancer
Several risk factors may help predict the chances of competing mortality -- or death from non-cancer causes -- in patients with head and neck cancer, according to research published online Nov. 23 in the Journal of Clinical Oncology.
LATEST ARTICLES
Skin may hold key to predicting cancer risk elsewhere in body
A cell biologist who has devoted much of his career to understanding the process of cancer argues that the skin may hold the key to predicting cancer risk of the colon, breast and more.
Making decision to allow child to die in comfort of her home, amidst chaos
Upon entering the cancer patient's home, it was clear that this dying girl's family lived and breathed--existed--solely to take care of her.
Flagellate pigmentation: Cutaneous manifestation continues to baffle dermatologists
Flagellate pigmentation is an uncommon and curious cutaneous manifestation commonly associated with systemic bleomycin chemotherapy.
Cancer and curcumin: Element in turmeric reduces radiation dermatitis
According to preliminary data, administration of curcumin diminishes the severity of radiation dermatitis, a common adverse event in cancer patients who are receiving radiation therapy.
Pralatrexate injection (Folotyn): Folate analogue metabolic inhibitor approved for treatment of relapsed or refractory peripheral T-cell lymphoma
New molecular entity: Pralatrexate injection (Folotyn) was approved on September 24, 2009, for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
eSamples check closet
eSamples check closet
Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Surgical Video Center
Surgical Video Center

On-demand surgery demos and presentations. Start Here



Click here